Next press panel announced
|
Hi! With ~1,600 oncology medicines and vaccines in development and the American Society of Clinical Oncology (ASCO) annual meeting around the corner, reporters are about to face a deluge of data and story pitches. So, among all of this information, what do journalists find compelling in a crowded news cycle? T2B’s Media Minds Roundtable is at it again. Their Q2 panel is called, “Top-Tier Perspective on ASCO and Beyond: How to Stand Out During Concentrated News Moments.” Taking place on Thursday, May 8th at 12-1 p.m. ET, it will provide a behind-the-scenes look at how reporters from WSJ, STAT, and Forbes approach deep therapeutic areas like oncology. As with all our roundtable events, this is exclusive to T2B Pro and Student members. Meet our panelistsThis panel, moderated by T2B Media Minds Roundtable members, will bring together three top-tier journalists to share how they assess the oncology landscape, select stories worth covering, and identify the trends that matter most:
Whether your company or clients are oncology-focused or not, this event will still be beneficial. I had fantasized when T2B launched in 2023 about having such amazing speakers and journalist access for our members, and it’s truly a pinch-me moment to see it happening – and driven by our members! Lynnea |
T2B Monthly
Hi! The outcomes of the annual American Society of Clinical Oncology (ASCO) meeting will flood the media landscape with clinical updates, milestone announcements, and analyst notes. So biopharma comms pros and storytellers must understand how to stand out during one of healthcare’s most concentrated news moments. Enter the Q2 Media Minds Panel: Oncology Reporting and ASCO Coverage. “Top-Tier Perspective on ASCO and Beyond: How to Stand Out During Concentrated News Moments” is happening...
Hi! Last week, the T2B community tackled the topic of trust. In an intriguing and very candid Comm Convo led by speakers Kris Baum (former FDA, CDER), Mary Kosinski (FleishmanHillard), and Sarah Spencer (Vor Bio), we explored how the relationships we build shape our ability to lead, influence, and respond. With so many specific anecdotes and practical tips shared, it was hard to narrow down to just 10 key takeaways, but we managed it (barely!): Leverage science as your trust anchor. When...
Hi! We’re all about bringing together the most creative minds in biopharma in a bid to secure and enhance the future of our profession. One of the many ways we do this is through our roundtables, which are driven directly by members who specialize in, and are passionate about, key areas of biopharma communications. And the next discipline on that roster is patient advocacy and engagement. Everything you need to know about the Patient Advocacy and Engagement Roundtable This roundtable will...